Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James B Bussel

Showing results (61-70 of 262) with videos related to

Pageof 27
Sort By:
Seminars in Hematology|January 13, 2015
Thrombopoietin receptor agonists: a critical reviewWilliam B Mitchell, James B Bussel
British Journal of Haematology|April 3, 2014
The coming of age of the megakaryocyte-plateletNichola Cooper, James B Bussel, Finbarr Cotter
Pediatric Blood & Cancer|November 1, 2022
Effects of COVID-19 vaccination on platelet counts and bleeding in children, adolescents, and young adults with immune thrombocytopeniaShipra Kaicker, Kirsten Martinko, James B Bussel
British Journal of Haematology|May 15, 2009
Cytomegalovirus can make immune thrombocytopenic purpura refractoryDina DiMaggio, Alan Anderson, James B Bussel
Pediatric Blood & Cancer|July 5, 2017
Imaging and management of fetuses and neonates with alloimmune thrombocytopeniaArzu Kovanlikaya, Priyanka Tiwari, James B Bussel
Blood|November 23, 2019
Identifying and treating refractory ITP: difficulty in diagnosis and role of combination treatmentOriana Miltiadous, Ming Hou, James B Bussel
Hematology. American Society of Hematology. Education Program|November 21, 2007
Novel thrombopoietic agentsBiree Andemariam, Bethan Psaila, James B Bussel
The New England Journal of Medicine|November 1, 2023
Primary Immune Thrombocytopenia in Pregnancy. ReplyJames B Bussel, Ming Hou, Douglas B Cines
Current Opinion in Oncology|October 9, 2008
The use of second-generation thrombopoietic agents for chemotherapy-induced thrombocytopeniaBenjamin Levy, Jon E Arnason, James B Bussel
British Journal of Haematology|January 5, 2020
Long-term sustained response to fostamatinib in two patients with chronic refractory immune thrombocytopenia (ITP)Eun-Ju Lee, Marina Izak, James B Bussel
Pageof 27

Showing results (61-70 of 262) with videos related to

Sort By:
Pageof 27
Seminars in Hematology|January 13, 2015
Thrombopoietin receptor agonists: a critical reviewWilliam B Mitchell, James B Bussel
British Journal of Haematology|April 3, 2014
The coming of age of the megakaryocyte-plateletNichola Cooper, James B Bussel, Finbarr Cotter
Pediatric Blood & Cancer|November 1, 2022
Effects of COVID-19 vaccination on platelet counts and bleeding in children, adolescents, and young adults with immune thrombocytopeniaShipra Kaicker, Kirsten Martinko, James B Bussel
British Journal of Haematology|May 15, 2009
Cytomegalovirus can make immune thrombocytopenic purpura refractoryDina DiMaggio, Alan Anderson, James B Bussel
Pediatric Blood & Cancer|July 5, 2017
Imaging and management of fetuses and neonates with alloimmune thrombocytopeniaArzu Kovanlikaya, Priyanka Tiwari, James B Bussel
Blood|November 23, 2019
Identifying and treating refractory ITP: difficulty in diagnosis and role of combination treatmentOriana Miltiadous, Ming Hou, James B Bussel
Hematology. American Society of Hematology. Education Program|November 21, 2007
Novel thrombopoietic agentsBiree Andemariam, Bethan Psaila, James B Bussel
The New England Journal of Medicine|November 1, 2023
Primary Immune Thrombocytopenia in Pregnancy. ReplyJames B Bussel, Ming Hou, Douglas B Cines
Current Opinion in Oncology|October 9, 2008
The use of second-generation thrombopoietic agents for chemotherapy-induced thrombocytopeniaBenjamin Levy, Jon E Arnason, James B Bussel
British Journal of Haematology|January 5, 2020
Long-term sustained response to fostamatinib in two patients with chronic refractory immune thrombocytopenia (ITP)Eun-Ju Lee, Marina Izak, James B Bussel
Pageof 27